{"transactions":[{"id":796867,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-30T21:43:20.000Z","date":"2026-04-29","kind":"other","planned":false,"acquired":true,"shares":233532,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax and estate planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees."}],"balance_after":286650,"source":{"system":"sec-edgar","filing":"0001628280-26-029041","document":"wk-form4_1777585398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026029041/wk-form4_1777585398.xml","form_type":"4"}},{"id":796866,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-30T21:43:20.000Z","date":"2026-04-29","kind":"other","planned":false,"acquired":false,"shares":233532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax and estate planning purposes."}],"balance_after":714613,"source":{"system":"sec-edgar","filing":"0001628280-26-029041","document":"wk-form4_1777585398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026029041/wk-form4_1777585398.xml","form_type":"4"}},{"id":813449,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-07T20:50:56.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":72559,"price":9.156,"value":664350.204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":948145,"source":{"system":"sec-edgar","filing":"0001628280-26-024098","document":"wk-form4_1775595054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026024098/wk-form4_1775595054.xml","form_type":"4"}},{"id":879704,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:54:33.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":14762,"price":9.5326,"value":140720.2412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":1020704,"source":{"system":"sec-edgar","filing":"0001628280-26-012390","document":"wk-form4_1772142870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026012390/wk-form4_1772142870.xml","form_type":"4"}},{"id":884995,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-02-25T00:09:28.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":570000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":570000,"derivative":{"exercise_price":7.56,"expiration_date":"2036-02-21","underlying":"Common  Stock","underlying_shares":570000},"source":{"system":"sec-edgar","filing":"0001628280-26-011327","document":"wk-form4_1771978165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011327/wk-form4_1771978165.xml","form_type":"4"}},{"id":884994,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-25T00:09:28.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":19039,"price":7.4528,"value":141893.8592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":1035466,"source":{"system":"sec-edgar","filing":"0001628280-26-011327","document":"wk-form4_1771978165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011327/wk-form4_1771978165.xml","form_type":"4"}},{"id":884993,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-25T00:09:28.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":1054505,"source":{"system":"sec-edgar","filing":"0001628280-26-011327","document":"wk-form4_1771978165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011327/wk-form4_1771978165.xml","form_type":"4"}},{"id":1177661,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-04T20:23:39.000Z","date":"2025-04-03","kind":"sale","planned":true,"acquired":false,"shares":79712,"price":5.9494,"value":474238.5728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":769505,"source":{"system":"sec-edgar","filing":"0001628280-25-016800","document":"wk-form4_1743798213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025016800/wk-form4_1743798213.xml","form_type":"4"}},{"id":1246306,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2025-02-25T20:36:01.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":480000,"derivative":{"exercise_price":9.57,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001628280-25-007693","document":"wk-form4_1740515751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007693/wk-form4_1740515751.xml","form_type":"4"}},{"id":1246305,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-25T20:36:01.000Z","date":"2025-02-24","kind":"sale","planned":true,"acquired":false,"shares":16122,"price":9.4534,"value":152407.7148,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":849217,"source":{"system":"sec-edgar","filing":"0001628280-25-007693","document":"wk-form4_1740515751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007693/wk-form4_1740515751.xml","form_type":"4"}},{"id":1246304,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-25T20:36:01.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":865339,"source":{"system":"sec-edgar","filing":"0001628280-25-007693","document":"wk-form4_1740515751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007693/wk-form4_1740515751.xml","form_type":"4"}},{"id":1482125,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:00:31.000Z","date":"2024-06-12","kind":"other","planned":false,"acquired":true,"shares":53118,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees."}],"balance_after":53118,"source":{"system":"sec-edgar","filing":"0001628280-24-027797","document":"wk-form4_1718222423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024027797/wk-form4_1718222423.xml","form_type":"4"}},{"id":1482124,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:00:31.000Z","date":"2024-06-12","kind":"other","planned":false,"acquired":false,"shares":53118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."}],"balance_after":625339,"source":{"system":"sec-edgar","filing":"0001628280-24-027797","document":"wk-form4_1718222423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024027797/wk-form4_1718222423.xml","form_type":"4"}},{"id":1547809,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-04T20:14:52.000Z","date":"2024-04-03","kind":"sale","planned":true,"acquired":false,"shares":72995,"price":9.4577,"value":690364.8115,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":678457,"source":{"system":"sec-edgar","filing":"0001628280-24-014878","document":"wk-form4_1712261678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024014878/wk-form4_1712261678.xml","form_type":"4"}},{"id":1619564,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-27T00:32:59.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":350000,"derivative":{"exercise_price":10.11,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001628280-24-006984","document":"wk-form4_1708993962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024006984/wk-form4_1708993962.xml","form_type":"4"}},{"id":1619563,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-27T00:32:59.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":751452,"source":{"system":"sec-edgar","filing":"0001628280-24-006984","document":"wk-form4_1708993962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024006984/wk-form4_1708993962.xml","form_type":"4"}},{"id":1843994,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T16:11:07.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":34000,"derivative":{"exercise_price":1.48,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-039688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919123039688/doc4.xml","form_type":"4"}},{"id":1928397,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T20:53:11.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":1152904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on April 3, 2024, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":1152904,"derivative":{"exercise_price":23.28,"expiration_date":"2033-04-02","underlying":"Common Stock","underlying_shares":1152904},"source":{"system":"sec-edgar","filing":"0001209191-23-022777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123022777/doc4.xml","form_type":"4"}},{"id":1928396,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-04T20:53:11.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":576452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":576452,"source":{"system":"sec-edgar","filing":"0001209191-23-022777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123022777/doc4.xml","form_type":"4"}},{"id":2056925,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T01:38:50.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":4593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options, which will vest in one installment on the first anniversary of the grant date."}],"balance_after":4593,"derivative":{"exercise_price":33.03,"exercise_date":"2024-01-10","expiration_date":"2033-01-10","underlying":"Common Stock","underlying_shares":4593},"source":{"system":"sec-edgar","filing":"0001209191-23-003081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123003081/doc4.xml","form_type":"4"}},{"id":2056924,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T01:38:50.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":7867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":31267,"source":{"system":"sec-edgar","filing":"0001209191-23-003081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123003081/doc4.xml","form_type":"4"}},{"id":2219182,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T16:14:06.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":17000,"derivative":{"exercise_price":3.53,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-22-039788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919122039788/doc4.xml","form_type":"4"}},{"id":2219181,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-29T16:14:06.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14083,"source":{"system":"sec-edgar","filing":"0001209191-22-039788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919122039788/doc4.xml","form_type":"4"}},{"id":2440700,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-08T01:07:23.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001209191-22-002586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122002586/doc4.xml","form_type":"4"}},{"id":2451959,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T02:31:37.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":272,"price":66.25,"value":18020.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."}],"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001209191-22-001323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122001323/doc4.xml","form_type":"4"}},{"id":2451958,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T02:31:37.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1984,"price":65.01,"value":128979.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.73 to $65.57, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":17272,"source":{"system":"sec-edgar","filing":"0001209191-22-001323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122001323/doc4.xml","form_type":"4"}},{"id":2451957,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T02:31:37.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":2244,"price":64.25,"value":144177.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.72 to\n$64.69, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":19256,"source":{"system":"sec-edgar","filing":"0001209191-22-001323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122001323/doc4.xml","form_type":"4"}},{"id":2488051,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T17:12:07.000Z","date":"2021-12-01","kind":"purchase","acquired":true,"shares":1150,"price":11.57,"value":13305.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $11.57, and the range of prices were between $11.38 and $11.79. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001209191-21-067658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919121067658/doc4.xml","form_type":"4"}},{"id":2591837,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-24T19:24:02.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":500,"price":19.63,"value":9815.0,"ownership":{"direct":true},"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001209191-21-053243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919121053243/doc4.xml","form_type":"4"}},{"id":2591836,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-24T19:24:02.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":500,"price":19.5,"value":9750.0,"ownership":{"direct":true},"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001209191-21-053243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919121053243/doc4.xml","form_type":"4"}},{"id":2655264,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-25T22:59:04.000Z","date":"2021-06-24","kind":"sale","acquired":false,"shares":5000,"price":89.85,"value":449250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.76 to $90.03, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":21500,"source":{"system":"sec-edgar","filing":"0001209191-21-043406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121043406/doc4.xml","form_type":"4"}},{"id":2656693,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T21:21:28.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":8583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":8583,"derivative":{"exercise_price":24.18,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":8583},"source":{"system":"sec-edgar","filing":"0001209191-21-042890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919121042890/doc4.xml","form_type":"4"}},{"id":2688434,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T16:08:03.000Z","date":"2021-05-28","kind":"purchase","acquired":true,"shares":600,"price":25.01,"value":15006.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The weighted average purchase price for the transaction reported was $25.01, and the range of prices were between $24.52 and $25.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $25.01, and the range of prices were between $24.52 and $25.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001209191-21-036799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919121036799/doc4.xml","form_type":"4"}},{"id":2893102,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T17:03:09.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in annual installments over 3 years following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares subject to the option vest in annual installments over 3 years following the date of grant."}],"balance_after":41200,"derivative":{"exercise_price":31.7,"underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0001209191-21-005710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000120919121005710/doc4.xml","form_type":"4"}},{"id":2923328,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:22:33.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":26500,"source":{"system":"sec-edgar","filing":"0001209191-21-001558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121001558/doc4.xml","form_type":"4"}},{"id":3000226,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-26T22:02:00.000Z","date":"2020-10-08","kind":"purchase","acquired":true,"shares":500,"price":50,"value":25000.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001209191-20-055851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120055851/doc4.xml","form_type":"4"}},{"id":3000225,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-26T22:02:00.000Z","date":"2020-10-08","kind":"purchase","acquired":true,"shares":500,"price":50.93,"value":25465.0,"ownership":{"direct":true},"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001209191-20-055851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120055851/doc4.xml","form_type":"4"}},{"id":3101272,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":500,"price":31.33,"value":15665.0,"ownership":{"direct":true},"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101271,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-04-15","kind":"purchase","acquired":true,"shares":500,"price":35.4,"value":17700.0,"ownership":{"direct":true},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101270,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":500,"price":23.94,"value":11970.0,"ownership":{"direct":true},"balance_after":15500,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101269,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":500,"price":24.8,"value":12400.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101268,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-03-11","kind":"purchase","acquired":true,"shares":500,"price":28.6,"value":14300.0,"ownership":{"direct":true},"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101267,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-02-28","kind":"purchase","acquired":true,"shares":500,"price":34.39,"value":17195.0,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101266,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-02-27","kind":"purchase","acquired":true,"shares":500,"price":35.07,"value":17535.0,"ownership":{"direct":true},"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3101265,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-24T22:10:45.000Z","date":"2020-01-13","kind":"purchase","acquired":true,"shares":500,"price":54.95,"value":27475.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-20-038767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/doc4.xml","form_type":"4"}},{"id":3324911,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":50577,"kind":"person","name":"De Backer Marianne","position":1,"cik":"0001797819","reported_name":"De Backer Marianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T23:10:56.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-20-001372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120001372/doc4.xml","form_type":"4"}}]}